about
A Systematic Review of the Anxiolytic-Like Effects of Essential Oils in Animal ModelsTransient anhedonia phenotype and altered circadian timing of behaviour during night-time dim light exposure in Per3-/- mice, but not wildtype mice.The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission.The mechanism of antidepressant-like effects of piroxicam in rats.5-HT6 receptor agonism facilitates emotional learning.Stretch, Shrink, and Shatter the Rhythms: The Intrinsic Circadian Period in Mania and Depression.Fish oil prevents rodent anxious states comorbid with diabetes: A putative involvement of nitric oxide modulation.Assessment of anxiety in patients who undergo surgical procedures for tooth implants: a prospective study.Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.Activation of postsynaptic D2 dopamine receptors in the rat dorsolateral striatum prevents the amnestic effect of systemically administered neuroleptics.The "anxiety state" and its relation with rat models of memory and habituation.The effect of oxcarbazepine on behavioural despair and learned helplessness.Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.[Medicinal plants for the treatment of generalized anxiety disorder: a review of controlled clinical studies].Spironolactone and low-dose dexamethasone enhance extinction of contextual fear conditioning.Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.Effects of Hypericum perforatum and paroxetine in the mouse defense test battery.Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats.Phosphatidylserine: an antidepressive or a cognitive enhancer?Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats.The relationship between dental anxiety in children, adolescents and their parents at dental environment.The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.Evaluation of 50-kHz ultrasonic vocalizations in animal models of mania: Ketamine and lisdexamfetamine-induced hyperlocomotion in rats.Myricitrin induces antidepressant-like effects and facilitates adult neurogenesis in mice.Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.Anti-fatigue activity of an arabinan-rich pectin from acerola (Malpighia emarginata).Quercetin reduces manic-like behavior and brain oxidative stress induced by paradoxical sleep deprivation in mice.Antidepressant-like effect of celecoxib piroxicam in rat models of depression.The roles of the nucleus accumbens core, dorsomedial striatum, and dorsolateral striatum in learning: performance and extinction of Pavlovian fear-conditioned responses and instrumental avoidance responses.Antimanic-like effects of (R)-(-)-carvone and (S)-(+)-carvone in mice.Evidence for an expanded time-window to mitigate a reactivated fear memory by tamoxifen.Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice.The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease.Social interaction with rat exposed to constant light during lactation prevents depressive-like behavior induced by constant light in adulthood.Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats.Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model.Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress.
P50
Q27024539-606FBA6E-2392-4D61-B073-DC8A31AE070FQ30834441-B5BF6E69-F191-464D-A2A2-36F17D5BB840Q31399944-BFC4FDDD-459C-4886-B3BC-BA49E50B9C1EQ35056335-51FF5D37-C7DD-4C57-98C4-50DC179CAACCQ36097366-7E07B137-3900-4837-8B83-25FC89D7B782Q38583069-E6B21D31-A0A9-4BD8-A3DA-B49729308C7DQ38913144-24C32BAA-CB8A-4592-836A-BA28635C9CE2Q41602825-19AF3D17-CB56-48BA-8ABE-0E7BD92CC1BEQ42447729-C48FC9A1-3D3C-437A-8114-FE51E2C674E3Q42470856-55C2F8B0-472A-4725-8F99-C169427FA9D8Q42607312-2CF2CA34-DE55-4E17-A21D-A64765A42D74Q42680186-CAD049DF-E505-4CEC-A16A-8D427BAE2744Q42683597-97313E22-963C-42D2-A90B-4598EAC71A4EQ42751572-D3F692AE-56EC-4D62-8F7A-23937F96C130Q42990425-D8C1AE34-CDD4-4D09-A96C-DEAB72DFF8BFQ43414542-5691F945-A976-431E-8C94-62CB116E67F8Q44200975-8D1EE898-0D7B-41C4-8707-0691C41E49F5Q44385011-8A602B6A-8146-4470-B675-CB4FAEFFD181Q44743025-330F277D-3448-43E0-9409-CBD549F6EB6CQ44994913-FF66C62B-15F7-47E0-A433-FADDC51ED3FDQ45003705-5D9A621B-AFAA-4EED-BF72-4177F7152D1EQ46127209-B9C3A0AF-38C0-4D6A-A824-5AE83562EBFBQ46310732-879B23AB-EE3B-4964-B5E5-CE852AFDC0B0Q47365679-A512D9AE-A9FF-4B62-BF7E-D9139954F1E9Q47403311-2E4D846F-8BF8-4CDE-8DD3-E03D4EFB2F18Q47662502-62438464-2238-4096-A575-AF57C559A4D4Q47705443-01AD6B13-6F3F-4B3C-9DA2-6838C30FD189Q47803678-5E2E37A4-7C6F-471D-8F09-7340CAA632A6Q47806667-E8B003B5-3E68-4C85-92B0-8A4973A11AE4Q47825212-F5FE038D-2C32-4752-8332-3642DEABEC26Q47877877-4A627E1C-8DDD-4D1F-9711-D2C5804C05D7Q47954528-467B946A-28B6-4EDA-B823-2FD170DFACB0Q48018851-9BBC4417-CB76-4FC4-91F1-6D831E64578AQ48082444-E7A57E80-7E3F-4D69-A5A2-884CD31CEB45Q48098959-5A1E20B6-660F-4414-8F72-CE6D8FC071C5Q48144562-83EC2C83-EA0F-4509-B05C-902965DF3CC1Q48175118-D744A8A0-401E-4D56-89E6-4183647F40E3Q48263467-5A088A9C-3A2C-4D85-BB79-8E87EBA25BACQ48274854-83EE94AF-7FBC-430B-8FD2-5E4064DBC29BQ48349214-41EB106C-EA8F-45DE-9A9E-65AB9E9276DA
P50
description
researcher ORCID ID = 0000-0002-8661-9132
@en
name
Roberto Andreatini
@ast
Roberto Andreatini
@en
Roberto Andreatini
@es
Roberto Andreatini
@nl
type
label
Roberto Andreatini
@ast
Roberto Andreatini
@en
Roberto Andreatini
@es
Roberto Andreatini
@nl
altLabel
Andreatini R
@en
prefLabel
Roberto Andreatini
@ast
Roberto Andreatini
@en
Roberto Andreatini
@es
Roberto Andreatini
@nl
P106
P1153
7003687393
P21
P31
P4012
P496
0000-0002-8661-9132